Profile data is unavailable for this security.
About the company
Meditera Tibbi Malzeme Sanayi ve Ticaret AS is a Turkey-based company, which is engaged in the design, productions, and wholesale trade of medical devices and equipment. The Company is specialized in the manufacture of anesthesia and intensive care circuits, the installation, operation and design of oncology drug preparation and delivery systems, production, sales and technical service of infusion pumps and sets, and the manufacture of biocidal products. Meditera Tibbi Malzeme manufactures surgical sutures and breathing circuits and accessories through its joint venture subsidiaries which established with Internacional Farmaceutica and S&Mohr. Additionally, The Company provides technical service, maintenance, and calibration services related to medical devices.
- Revenue in TRY (TTM)2.49bn
- Net income in TRY-50.61m
- Incorporated1996
- Employees808.00
- LocationMeditera Tibbi Malzeme Sanayi ve Ticaret ASTire OSBIZMIR 35900TurkeyTUR
- Phone+90 2 325135110
- Fax+90 2 322539404
- Websitehttps://www.meditera.com.tr
More ▼
Mergers & acquisitions
| Acquired company | MEDTR.E:IST since announced | Transaction value |
|---|---|---|
| ALTERA Medikal Sanayi ve Ticaret AS | -4.60% | 316.00k |
Data delayed at least 15 minutes, as of Mar 03 2026 15:05 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gentian Diagnostics ASA | 809.60m | 60.81m | 2.75bn | 63.00 | 45.99 | 2.93 | 26.82 | 3.40 | 0.8459 | 0.8459 | 11.35 | 13.29 | 0.7231 | 1.56 | 6.36 | -- | 5.43 | -0.0483 | 6.25 | -0.055 | 55.64 | 47.27 | 7.51 | -0.0788 | 3.81 | -- | 0.0866 | -- | 16.07 | 22.75 | -70.73 | -- | 10.72 | -- |
| AbL Diagnostics SA | 279.91m | 23.80m | 2.85bn | 20.00 | 119.53 | 7.98 | 46.03 | 10.17 | 0.0288 | 0.0288 | 0.3383 | 0.4308 | 0.4416 | -- | 1.60 | 286,763.20 | 3.76 | 3.59 | 5.34 | 5.29 | -- | -- | 8.50 | 8.20 | 2.91 | -- | 0.2788 | -- | -5.03 | -- | 424.60 | -- | -- | -- |
| Optomed Oyj | 878.23m | -341.12m | 2.92bn | 111.00 | -- | 2.36 | -- | 3.32 | -0.3374 | -0.3374 | 0.8688 | 1.12 | 0.5363 | 2.87 | 5.07 | 154,009.00 | -20.83 | -17.19 | -25.75 | -20.69 | 63.60 | 64.81 | -38.85 | -34.21 | 2.03 | -8.91 | 0.1014 | -- | 13.67 | 5.61 | -21.83 | -- | 5.30 | -- |
| Nanexa AB | 173.44m | -54.64m | 3.01bn | 15.00 | -- | 6.11 | 545.28 | 17.35 | -0.0724 | -0.0724 | 0.2255 | 0.6237 | 0.3144 | 16.22 | 5.23 | 2,409,933.00 | -9.90 | -31.63 | -12.96 | -38.78 | 86.02 | 96.94 | -31.50 | -218.01 | 1.51 | -3.21 | 0.0109 | -- | 48.39 | 72.50 | 54.27 | -- | 3.54 | -- |
| BioPorto A/S | 251.42m | -596.86m | 3.06bn | 48.00 | -- | 11.63 | -- | 12.19 | -0.1973 | -0.1973 | 0.083 | 0.0774 | 0.4132 | 2.55 | 4.69 | 962,131.60 | -98.08 | -65.22 | -133.92 | -88.74 | 63.90 | 64.15 | -237.40 | -222.22 | 1.71 | -- | 0.1916 | -- | 17.07 | 6.36 | -21.15 | -- | -20.56 | -- |
| Ondine Biomedical Inc | 70.82m | -768.14m | 3.15bn | 43.00 | -- | 115.16 | -- | 44.47 | -0.0358 | -0.0358 | 0.0032 | 0.0009 | 0.3447 | 0.5771 | 8.03 | -- | -373.83 | -- | -4,807.85 | -- | 65.77 | -- | -1,084.66 | -- | 0.7948 | -- | 0.4333 | -- | 70.32 | -- | -32.51 | -- | -- | -- |
| Meditera Tibbi Mlzm Sny Tcrt AS | 2.49bn | -50.61m | 3.25bn | 808.00 | -- | 1.17 | 34.48 | 1.30 | -0.4253 | -0.4253 | 20.94 | 23.28 | 0.8108 | 2.84 | 4.85 | 3,257,490.00 | -1.87 | 6.25 | -2.23 | 7.47 | 32.70 | 42.44 | -2.31 | 6.90 | 2.17 | -- | 0.01 | 180.36 | -0.1151 | 55.27 | 96.62 | 41.97 | -- | -- |
| OssDsign AB | 864.39m | -244.64m | 3.32bn | 32.00 | -- | 2.23 | -- | 3.84 | -0.5493 | -0.5493 | 2.06 | 2.80 | 0.5109 | 0.3672 | 6.95 | 5,629,938.00 | -14.46 | -25.42 | -16.05 | -28.59 | 96.29 | 85.57 | -28.30 | -82.42 | 6.33 | -13.77 | 0.0044 | -- | 34.51 | 48.59 | -2.68 | -- | 24.28 | -- |
| Senzime AB (publ) | 499.09m | -659.34m | 3.40bn | 50.00 | -- | 2.33 | -- | 6.81 | -0.9396 | -0.9396 | 0.7073 | 1.94 | 0.2619 | 2.61 | 7.48 | -- | -34.60 | -36.25 | -37.96 | -39.02 | 33.35 | 24.11 | -132.11 | -271.04 | 3.04 | -7.45 | 0.044 | -- | 77.89 | 61.95 | -15.74 | -- | 123.16 | -- |
| Fonet Bilgi Teknolojileri AS | 826.20m | 220.17m | 3.44bn | 527.00 | 15.64 | 2.04 | 9.35 | 4.17 | 0.2352 | 0.2352 | 0.8827 | 1.81 | 0.483 | -- | 8.97 | 1,567,740.00 | 12.87 | 15.26 | 13.72 | 16.63 | 39.79 | 33.90 | 26.65 | 32.10 | -- | -- | 0.0309 | -- | 35.94 | 67.47 | 13.34 | 51.70 | 66.70 | -- |
| Creo Medical Group PLC | 129.65m | 742.55m | 3.59bn | 133.00 | 4.99 | 0.999 | 4.38 | 27.65 | 0.0296 | 0.0272 | 0.0056 | 0.1477 | 0.0319 | -0.8034 | 0.3308 | 16,541.35 | 18.25 | -29.25 | 20.62 | -35.89 | 45.45 | 47.22 | 572.73 | -176.82 | 4.75 | -69.50 | 0.0645 | -- | 0.00 | 212.28 | -17.30 | -- | -18.58 | -- |
| Nexstim Oyj | 517.06m | -14.54m | 3.71bn | 40.00 | -- | 22.59 | 108.67 | 7.17 | -0.042 | -0.042 | 1.47 | 0.4426 | 0.8553 | 0.5613 | 4.66 | 251,616.80 | -2.40 | -12.40 | -4.17 | -20.76 | 94.36 | 95.09 | -2.81 | -16.29 | 1.08 | 0.7835 | 0.6002 | -- | 20.55 | 21.14 | 32.79 | -- | 15.13 | -- |
| Medicalgorithmics SA | 324.79m | -186.41m | 3.76bn | 117.00 | -- | 4.71 | -- | 11.59 | -1.55 | -1.55 | 2.69 | 6.62 | 0.252 | 0.3913 | 6.83 | 229,034.20 | -14.46 | -3.04 | -15.68 | -3.62 | 87.28 | 85.62 | -57.38 | -8.77 | 1.25 | -15.74 | 0.2309 | -- | -44.31 | -32.70 | -2,682.18 | -- | -48.46 | -- |
| Agfa Gevaert NV | 56.77bn | -3.65bn | 3.80bn | 4.74k | -- | 0.2579 | -- | 0.067 | -0.468 | -0.4796 | 6.77 | 1.85 | 0.8252 | 2.39 | 4.78 | 233,073.20 | -5.15 | -4.74 | -7.10 | -6.86 | 29.77 | 29.67 | -6.24 | -6.36 | 1.17 | 2.50 | 0.3798 | -- | -1.04 | -10.44 | -71.70 | -- | 3.44 | -- |
| Omda AS | 2.27bn | 30.31m | 3.84bn | 260.00 | 122.01 | 30.76 | 11.44 | 1.69 | 0.3279 | 0.3279 | 24.52 | 1.30 | 0.6205 | 222.71 | 12.78 | -- | 0.8295 | -4.34 | 1.20 | -5.68 | 93.17 | 91.86 | 1.34 | -8.19 | 0.7752 | 0.8344 | 0.9483 | -- | 15.55 | 16.62 | 109.90 | -- | 12.15 | -- |
Data as of Mar 03 2026. Currency figures normalised to Meditera Tibbi Malzeme Sanayi ve Ticaret AS's reporting currency: Turkish Lira TRY
5.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Azimut Portf�y Y�netimi ASas of 14 Aug 2024 | 6.26m | 5.26% |
| HSBC Portf�y Y�netim ASas of 31 Dec 2025 | 44.70k | 0.04% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 1.50k | 0.00% |
Data from 30 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
